查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458774

2024 年连网型给药设备全球市场报告

Connected Drug Delivery Devices Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

连网型药物输送设备的市场规模预计在未来几年将大幅成长。 2028年，这一数字将以24%的复合年增长率成长至176.7亿美元。预测期内的预期增长是由于慢性病患病率不断上升、患者对遵守处方治疗方法的认识不断提高、医疗保健IT基础设施的快速发展、对预防性医疗保健、电子保健的日益重视，这是由于连网型设备的广泛采用在实验室和医院中保存电子健康记录(EHR)。预计这段时期的主要趋势包括研发活动的增加、技术创新和设备远端医疗的激增、机器学习和人工智慧的采用增加以及与扩增实境/虚拟实境 (AR/VR) 技术的整合。以及医疗设备中电子技术的日益采用。

远端患者监护(RPM) 的重要性日益增加，预计将推动连网型给药设备市场的成长。远端患者监护是一种医疗保健提供方法，利用技术从远端位置监控患者的健康状况和医疗资料。连网型的药物输送设备透过准确追踪药物使用和药物依从性、促进及时干预并提供个人化护理管理，在提高 RPM 方面发挥关键作用。例如，美国数位健康解决方案供应商Vivalink Inc. 在2023 年8 月进行的一项调查发现，305% 的临床医生在患者身上使用RPM，从2021 年的20% 上升到如今的81%，显着增加。因此，远端患者监护的重要性日益增加，正在推动连网药物输送市场的成长。

连网型给药设备市场的主要企业专注于开拓创新技术，例如数位呼吸健康解决方案，以提高市场盈利。用于连网型药物输送设备的数位呼吸健康解决方案包括技术支援的设备，这些设备有助于将药物输送到呼吸系统，同时监控使用情况和健康资料，以改善患者的治疗效果。例如，2022 年 2 月，美国药品包装和药物传输设备製造商 AptarGroup Inc. 发布了 HeroTracker Sense。这种创新的数位工具将传统的计量吸入器转变为智慧连网型设备，可增强气喘和慢性阻塞性肺病等慢性呼吸道疾病患者的用药依从性和管理。它包含用于分析和洞察的传感器等功能，以支持患者用药依从性和透过 BreatheSmart 应用程式进行监控，以帮助有效管理呼吸系统疾病。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球连网型给药设备市场，依类型、实际及预测细分，2018-2023、2023-2028、2033
  • 独立组件和软体
  • 整合装置
  • 全球连网型给药设备市场，依技术、效能及预测细分，2018-2023、2023-2028、2033
  • 蓝牙
  • 近场通讯（NFC）
  • 其他技术
  • 全球连网型给药设备市场，依管理细分、实际及预测，2018-2023、2023-2028、2033
  • 胃肠外的
  • 吸入
  • 全球连网型给药设备市场，依应用细分、实际及预测，2018-2023、2023-2028、2033
  • 气喘
  • 慢性阻塞性肺病
  • 糖尿病管理
  • 其他应用

第 7 章 区域/国家分析

  • 全球连网型给药设备市场，依地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球连网型给药设备市场，依国家、表现及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 连网型给药设备市场的竞争格局
  • 连网型药物输送设备市场公司概况
    • Pfizer Inc.
    • Johnson &Johnson
    • Bayer AG
    • AstraZeneca PLC
    • Abbott Laboratories

第31章 其他大型创新企业

  • Novartis AG
  • Medtronic PLC
  • Eli Lilly and Company
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • Novo Nordisk A/S
  • Merck Group
  • Becton Dickinson and Company
  • GlaxoSmithKline PLC
  • Phillips-Medisize Corporation
  • AptarGroup Inc.
  • Dexcom Inc.
  • West Pharmaceutical Services Inc.
  • Insulet Corporation
  • OPKO Health Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r16756

Connected drug delivery devices are advanced pharmaceutical tools that employ digital technology to monitor, regulate, and oversee the dispensing of medications, thereby improving adherence and patient outcomes. These devices are capable of internet connectivity, enabling data exchange between patients and healthcare providers to monitor medication usage, adjust dosages, and enhance treatment strategies.

The primary categories of connected drug delivery devices encompass standalone components, software, and integrated devices. Standalone components and software denote software or hardware capable of functioning independently or separately from a medical device that generates or utilizes it. They leverage various technologies such as Bluetooth, near-field communication (NFC), and others. These devices cater to a range of routes of administration including parenteral and inhalational methods, and find applications in conditions like asthma, chronic obstructive pulmonary disease, diabetes management, among others.

The connected drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides connected drug delivery devices market statistics, including connected drug delivery devices industry global market size, regional shares, competitors with a connected drug delivery devices market share, detailed connected drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the connected drug delivery devices industry. This connected drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The connected drug delivery market size has grown exponentially in recent years. It will grow from $6.02 billion in 2023 to $7.48 billion in 2024 at a compound annual growth rate (CAGR) of 24.3%. The expansion witnessed in the historical period can be attributed to heightened awareness surrounding connected devices, the growing significance of remote monitoring for medication adherence, increased patient engagement, widespread adoption among consumers, and the rapidly escalating costs associated with medical management.

The connected drug delivery market size is expected to see exponential growth in the next few years. It will grow to $17.67 billion in 2028 at a compound annual growth rate (CAGR) of 24%. The anticipated growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, growing patient awareness regarding adherence to prescribed therapies, the rapid evolution of healthcare IT infrastructure, a heightened emphasis on preventive care, and the widespread adoption of connected devices in laboratories and hospitals for the maintenance of electronic health records (EHR). Major trends expected in this period encompass a rise in research and development activities, a surge in technological innovation and device connectivity, an increasing adoption of machine learning and artificial intelligence, a rising implementation of telehealth platforms integrated with augmented reality/virtual reality (AR/VR) technologies, and an increasing adoption of electronic technology in healthcare devices.

The growth of the connected drug delivery device market is anticipated to be propelled by the increasing significance of remote patient monitoring (RPM). Remote patient monitoring is a healthcare delivery method utilizing technology to monitor patient health and medical data from a distance. Connected drug delivery devices play a crucial role in enhancing RPM by enabling precise tracking of medication usage and adherence, facilitating timely interventions, and offering personalized care management. For example, a survey conducted by Vivalink Inc., a US-based digital health solutions provider, in August 2023, revealed a significant increase of 305% in clinicians utilizing RPM on patients, rising from 20% in 2021 to 81% presently, with 84% of these users planning to expand their RPM usage in 2024. Consequently, the growing importance of remote patient monitoring is propelling the growth of the connected drug delivery device market.

Major players in the connected drug delivery devices market are concentrating on developing innovative technologies, such as digital respiratory health solutions, to enhance their market profitability. Digital respiratory health solutions for connected drug delivery devices encompass technology-enabled devices facilitating medication delivery to the respiratory system while monitoring usage and health data to improve patient outcomes. For instance, in February 2022, AptarGroup Inc., a US-based manufacturer of dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital tool transforms traditional metered-dose inhalers into smart, connected devices, enhancing medication adherence and management for individuals with chronic respiratory conditions like asthma and COPD. It incorporates features such as sensors for analytics and insights, supporting patient adherence monitoring via the BreatheSmart app, thereby aiding in the effective management of respiratory diseases.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for an undisclosed sum. This acquisition is expected to bolster Halozyme's strategy, solidify its position as a top drug delivery firm, and expand its coverage of specialized products with its best-in-class auto-injector technology and specialty commercial business. Antares Pharma Inc. is a US-based specialty pharmaceutical company operating in the connected drug delivery sector.

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

North America was the largest region in the connected drug delivery market in 2023. The regions covered in connected drug delivery device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the connected drug delivery device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The connected drug delivery device market consists of revenues earned by entities by providing services such as medication reminders and alerts, dose tracking, data sharing, adjustable dosing, and integration with health records. The market value includes the value of related goods sold by the service provider or included within the service offering. The connected drug delivery device market also includes sales of smart inhalers, connected insulin pumps, smart pill dispensers, wearable drug delivery devices, and digital pills that are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Connected Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on connected drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for connected drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The connected drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Standalone Components And Software; Integrated Devices
  • 2) By Technology: Bluetooth; Near-Field Communication (NFC); Other Technologies
  • 3) By Administration: Parenteral; Inhalational
  • 4) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Diabetes Management; Other Applications
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; AstraZeneca PLC; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Connected Drug Delivery Devices Market Characteristics

3. Connected Drug Delivery Devices Market Trends And Strategies

4. Connected Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Connected Drug Delivery Devices Market Size and Growth

  • 5.1. Global Connected Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Connected Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Connected Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Connected Drug Delivery Devices Market Segmentation

  • 6.1. Global Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Standalone Components And Software
  • Integrated Devices
  • 6.2. Global Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bluetooth
  • Near-Field Communication (NFC)
  • Other Technologies
  • 6.3. Global Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Parenteral
  • Inhalational
  • 6.4. Global Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Diabetes Management
  • Other Applications

7. Connected Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Connected Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Connected Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Connected Drug Delivery Devices Market

  • 8.1. Asia-Pacific Connected Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Connected Drug Delivery Devices Market

  • 9.1. China Connected Drug Delivery Devices Market Overview
  • 9.2. China Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Connected Drug Delivery Devices Market

  • 10.1. India Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Connected Drug Delivery Devices Market

  • 11.1. Japan Connected Drug Delivery Devices Market Overview
  • 11.2. Japan Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Connected Drug Delivery Devices Market

  • 12.1. Australia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Connected Drug Delivery Devices Market

  • 13.1. Indonesia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Connected Drug Delivery Devices Market

  • 14.1. South Korea Connected Drug Delivery Devices Market Overview
  • 14.2. South Korea Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Connected Drug Delivery Devices Market

  • 15.1. Western Europe Connected Drug Delivery Devices Market Overview
  • 15.2. Western Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Connected Drug Delivery Devices Market

  • 16.1. UK Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Connected Drug Delivery Devices Market

  • 17.1. Germany Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Connected Drug Delivery Devices Market

  • 18.1. France Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Connected Drug Delivery Devices Market

  • 19.1. Italy Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Connected Drug Delivery Devices Market

  • 20.1. Spain Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Connected Drug Delivery Devices Market

  • 21.1. Eastern Europe Connected Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Connected Drug Delivery Devices Market

  • 22.1. Russia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Connected Drug Delivery Devices Market

  • 23.1. North America Connected Drug Delivery Devices Market Overview
  • 23.2. North America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Connected Drug Delivery Devices Market

  • 24.1. USA Connected Drug Delivery Devices Market Overview
  • 24.2. USA Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Connected Drug Delivery Devices Market

  • 25.1. Canada Connected Drug Delivery Devices Market Overview
  • 25.2. Canada Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Connected Drug Delivery Devices Market

  • 26.1. South America Connected Drug Delivery Devices Market Overview
  • 26.2. South America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Connected Drug Delivery Devices Market

  • 27.1. Brazil Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Connected Drug Delivery Devices Market

  • 28.1. Middle East Connected Drug Delivery Devices Market Overview
  • 28.2. Middle East Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Connected Drug Delivery Devices Market

  • 29.1. Africa Connected Drug Delivery Devices Market Overview
  • 29.2. Africa Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Connected Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Connected Drug Delivery Devices Market Competitive Landscape
  • 30.2. Connected Drug Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AstraZeneca PLC
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Connected Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Medtronic PLC
  • 31.3. Eli Lilly and Company
  • 31.4. Amgen Inc.
  • 31.5. Boehringer Ingelheim International GmbH
  • 31.6. Novo Nordisk A/S
  • 31.7. Merck Group
  • 31.8. Becton Dickinson and Company
  • 31.9. GlaxoSmithKline PLC
  • 31.10. Phillips-Medisize Corporation
  • 31.11. AptarGroup Inc.
  • 31.12. Dexcom Inc.
  • 31.13. West Pharmaceutical Services Inc.
  • 31.14. Insulet Corporation
  • 31.15. OPKO Health Inc.

32. Global Connected Drug Delivery Devices Market Competitive Benchmarking

33. Global Connected Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Connected Drug Delivery Devices Market

35. Connected Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Connected Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Connected Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Connected Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer